Inotiv Inc. (NOTV) Insider Trading
Insiders sold $67k and bought nothing on the open market.
16% of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Dec 2024.
Get an email when NOTV's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17 | Robert Leasure Jr. President and CEO | Sold10b5-1 plan | 16,810 | $0.30 | $5k | 1.2% | Form 4 |
| Feb 17 | John E Sagartz Chief Strategy Officer | Sold10b5-1 plan | 2,119 | $0.29 | $615 | 0.3% | Form 4 |
| Feb 17 | Beth A. Taylor Chief Financial Officer | Sold10b5-1 plan | 2,888 | $0.29 | $838 | 1.9% | Form 4 |
| Feb 2 | Robert Leasure Jr. President and CEO | SoldNo plan | 113,297 | $0.50 | $57k | 7.6% | Form 4 |
| Dec 1, 2025 | R Matthew Neff Director | Sold10b5-1 plan | 2,000 | $0.89 | $2k | 1.3% | Form 4 |
| Nov 3, 2025 | R Matthew Neff Director | Sold10b5-1 plan | 2,000 | $1.24 | $2k | 1.3% | Form 4 |
| Oct 1, 2025 | R Matthew Neff Director | Sold10b5-1 plan | 2,000 | $1.43 | $3k | 1.4% | Form 4 |
| Sep 2, 2025 | R Matthew Neff Director | Sold10b5-1 plan | 2,000 | $1.67 | $3k | 1.3% | Form 4 |
| Aug 1, 2025 | R Matthew Neff Director | Sold10b5-1 plan | 2,000 | $1.91 | $4k | 1.3% | Form 4 |
| Jul 1, 2025 | R Matthew Neff Director | Sold10b5-1 plan | 2,000 | $1.81 | $4k | 1.3% | Form 4 |
| Jun 2, 2025 | R Matthew Neff Director | Sold10b5-1 plan | 2,000 | $2.62 | $5k | 1.3% | Form 4 |
| Apr 1, 2025 | Mary Theresa Coelho Director | SoldNo plan | 5,500 | $2.35 | $13k | 6.9% | Form 4 |
| Feb 18, 2025 | Jeffrey Brennan Freeman VP-Finance & Corp. Controller | SoldNo plan | 1,339 | $4.05 | $5k | 4.6% | Form 4 |
| Feb 18, 2025 | Beth Taylor Chief Financial Officer | SoldNo plan | 4,370 | $4.01 | $18k | 3.9% | Form 4 |
| Feb 18, 2025 | John E Sagartz Chief Strategy Officer | SoldNo plan | 2,113 | $3.94 | $8k | 0.3% | Form 4 |
| Feb 18, 2025 | Robert Leasure Jr. President and CEO | SoldNo plan | 73,617 | $3.82 | $281k | 6.5% | Form 4 |
| Jan 31, 2025 – Feb 3, 2025 | Jeffrey Arthur Krupp Chief Human Resources Officer | SoldNo plan 2 parts | 2,508 | $4.42 average | $11k | 8.1% | Form 4 |
| Jan 31, 2025 | Robert Leasure Jr. President and CEO | SoldNo plan | 22,700 | $4.15 | $94k | 2.0% | Form 4 |
| Jan 31, 2025 | Beth Taylor Chief Financial Officer | SoldNo plan | 2,054 | $4.47 | $9k | 1.8% | Form 4 |
| Jan 31, 2025 | John E Sagartz Chief Strategy Officer | SoldNo plan | 2,118 | $4.48 | $9k | 0.3% | Form 4 |
| Dec 19, 2024 | David Landman Director | Bought | 23,529 | $4.25 | $100k | 15% | Form 4 |
| Dec 10, 2024 | John Gregory Beattie Chief Operating Officer | Bought | 30,000 | $4.75 | $143k | 23% | Form 4 |
| Dec 10, 2024 | Nigel Brown Director | Bought | 7,500 | $4.26 | $32k | 13% | Form 4 |
| Dec 6, 2024 | Michael J Harrington Director | Bought | 10,000 | $3.98 | $40k | 36% | Form 4 |
| Dec 6, 2024 | David Landman Director | Bought | 100,000 | $4.14 | $414k | 188% | Form 4 |
- Feb 1710b5-1 planRobert Leasure Jr.President and CEO · sold 16,810 at $0.30$5k1.2% of stake
- Feb 1710b5-1 planJohn E SagartzChief Strategy Officer · sold 2,119 at $0.29$6150.3% of stake
- Feb 1710b5-1 planBeth A. TaylorChief Financial Officer · sold 2,888 at $0.29$8381.9% of stake
- Feb 2No planRobert Leasure Jr.President and CEO · sold 113,297 at $0.50$57k7.6% of stake
- Dec 1, 202510b5-1 planR Matthew NeffDirector · sold 2,000 at $0.89$2k1.3% of stake
- Nov 3, 202510b5-1 planR Matthew NeffDirector · sold 2,000 at $1.24$2k1.3% of stake
- Oct 1, 202510b5-1 planR Matthew NeffDirector · sold 2,000 at $1.43$3k1.4% of stake
- Sep 2, 202510b5-1 planR Matthew NeffDirector · sold 2,000 at $1.67$3k1.3% of stake
- Aug 1, 202510b5-1 planR Matthew NeffDirector · sold 2,000 at $1.91$4k1.3% of stake
- Jul 1, 202510b5-1 planR Matthew NeffDirector · sold 2,000 at $1.81$4k1.3% of stake
- Jun 2, 202510b5-1 planR Matthew NeffDirector · sold 2,000 at $2.62$5k1.3% of stake
- Apr 1, 2025No planMary Theresa CoelhoDirector · sold 5,500 at $2.35$13k6.9% of stake
- Feb 18, 2025No planJeffrey Brennan FreemanVP-Finance & Corp. Controller · sold 1,339 at $4.05$5k4.6% of stake
- Feb 18, 2025No planBeth TaylorChief Financial Officer · sold 4,370 at $4.01$18k3.9% of stake
- Feb 18, 2025No planJohn E SagartzChief Strategy Officer · sold 2,113 at $3.94$8k0.3% of stake
- Feb 18, 2025No planRobert Leasure Jr.President and CEO · sold 73,617 at $3.82$281k6.5% of stake
- Jan 31, 2025 – Feb 3, 2025No planJeffrey Arthur KruppChief Human Resources Officer · sold 2,508 at avg $4.42$11k8.1% of stake
- Jan 31, 2025No planRobert Leasure Jr.President and CEO · sold 22,700 at $4.15$94k2.0% of stake
- Jan 31, 2025No planBeth TaylorChief Financial Officer · sold 2,054 at $4.47$9k1.8% of stake
- Jan 31, 2025No planJohn E SagartzChief Strategy Officer · sold 2,118 at $4.48$9k0.3% of stake
- Dec 19, 2024David LandmanDirector · bought 23,529 at $4.25$100k15% of stake
- Dec 10, 2024John Gregory BeattieChief Operating Officer · bought 30,000 at $4.75$143k23% of stake
- Dec 10, 2024Nigel BrownDirector · bought 7,500 at $4.26$32k13% of stake
- Dec 6, 2024Michael J HarringtonDirector · bought 10,000 at $3.98$40k36% of stake
- Dec 6, 2024David LandmanDirector · bought 100,000 at $4.14$414k188% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Services-Commercial Physical & Biological Research
Spot a number that looks wrong? Check it in NOTV's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NOTV
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.